Keywords: Puncture needle (microneedle), manufacturer, product design, clinical application, transdermal drug delivery

A microneedle is not a single standalone product, but a comprehensive technology platform. Its product forms and design details are fully tailored to specific clinical scenarios. Ranging from pain-free vaccination and precise tumor therapy to daily skincare and chronic disease management, diverse demands have given rise to microneedle products with varied shapes and functions. For manufacturers, gaining in-depth insights into clinical pain points and translating them into accurate design specifications is the key to product success.

I. Classification by Mechanism and Structure: Four Mainstream Technical Routes

• Solid MicroneedlesAs the earliest form of microneedles, solid shafts contain no drugs. They are mainly used to create microchannels on the skin, followed by topical application of pharmaceuticals or cosmetics to enhance permeation. The core design priorities lie in penetration efficiency and fracture prevention. Currently, they are mostly adopted as penetration enhancers for cosmetics and combined drug delivery.
• Coated MicroneedlesA drug-containing coating is applied onto the surface of solid microneedles, which are generally made of metal or insoluble polymers. After penetrating the skin, the coating dissolves rapidly to release loaded drugs. This type features relatively simple manufacturing yet limited drug loading capacity. It is commonly used for vaccinations such as influenza vaccines and fast-acting medications.
• Dissolvable MicroneedlesThey represent the mainstream direction of current research and industrialization. Needles are fabricated by mixing biodegradable polymers including PVP, hyaluronic acid and PLGA with active drugs. Upon skin penetration, the needles dissolve in interstitial fluid and fully release the encapsulated drugs. Realizing needle-free, painless and non-invasive administration, they are compatible with small molecules, proteins, nucleic acids and various other drugs, making them ideal carriers for transdermal drug delivery.
• Hollow MicroneedlesShaped like miniature syringes with internal hollow lumens, they deliver liquid medications via external pumps or capillary action after insertion. They are suitable for administering high-dose or high-viscosity drugs such as insulin. Major design challenges include the fabrication of micron-scale hollow channels and anti-clogging performance.

II. Design Philosophy Driven by Clinical Application Scenarios

1. Vaccination and Immunization

• Clinical demands: Improve accessibility (no requirement for professional medical staff), eliminate needle phobia, and boost immune response thanks to abundant immune cells in the skin.
• Design solutions: Dissolvable microneedle array patches are widely used. Needle length is typically set between 500 and 800 micrometers to deliver antigens to the epidermis rich in Langerhans cells. Special formulations ensure long-term stability of vaccines, especially unstable mRNA vaccines, at room temperature to resolve cold chain transportation issues. Manufacturers are cooperating with major pharmaceutical enterprises to develop microneedle patches for influenza, COVID-19, measles and other infectious diseases.

2. Chronic Disease Management (e.g. Diabetes)

• Clinical demands: Enable pain-free, convenient and on-demand insulin administration to improve patient compliance.
• Design solutions: Hollow microneedles are integrated with micro-pumps to form wearable smart insulin pumps. Glucose-responsive dissolvable microneedles are also developed, whose polymer matrix automatically adjusts insulin release rate according to blood glucose levels to achieve closed-loop therapy. The needles must possess sufficient mechanical strength for skin penetration and work seamlessly with control systems to guarantee accurate dosing.

3. Medical Aesthetics and Dermatology

• Clinical demands: Efficiently deliver active cosmetic ingredients such as hyaluronic acid, collagen and whitening agents, stimulate collagen regeneration, and treat acne scars.
• Design solutions: This is one of the most commercially mature sectors for microneedles with a wide range of product forms:
• Permeation-enhancing rollers and stamps: Mostly equipped with solid metal microneedles for home use. After creating microchannels mechanically, skincare serums are applied topically.
• Dissolvable microneedle eye masks and facial masks: Hyaluronic acid, peptides and other ingredients are directly embedded into microneedles, which dissolve and get absorbed immediately after application for easy use.
• Radiofrequency microneedles: Combining insulated microneedles with radiofrequency energy. After reaching the dermis, the devices emit controlled thermal energy to trigger collagen remodeling, serving for skin tightening, anti-aging and scar treatment. Classified as Class III medical devices, such products are subject to strict regulations, with extremely high requirements for needle insulation and precise energy control.

4. Diagnosis and Monitoring

• Clinical demands: Painless and continuous collection of skin interstitial fluid to detect biomarkers including glucose, lactic acid and drug concentrations.
• Design solutions: Microneedles integrated with biosensing elements are developed. The needle surface is modified with specific enzymes or antibodies, which react with target substances in interstitial fluid and generate detectable electrical or optical signals. Such products require good compatibility between microneedle materials and sensing layers, as well as stable and reliable signal output.

III. Manufacturers' Design Workflow: From Clinical Insights to Product Definition

Successful microneedle products originate from thorough clinical research. The R&D process of leading manufacturers generally includes the following steps:

• Demand exploration: Conduct in-depth communication with clinicians, pharmacists and patients to identify unmet clinical needs, such as pain caused by insulin injection and reliance on cold chain for vaccines.
• Target Product Profile (TPP) formulation: Define key performance indicators, including drug loading capacity, release kinetics (immediate release or sustained release for weeks), penetration success rate (over 95%), application duration and storage stability.
• Translation of design inputs: Convert the TPP into specific technical parameters: select needle materials based on drug properties and release requirements; determine needle length and array density according to target skin layer thickness and administration area; adopt conical or pyramidal needle shapes to optimize penetration performance; design rigid or flexible substrates to adapt to different body parts.
• Design verification and validation: Conduct computer simulation, ex vivo skin tests and animal experiments, followed by clinical trials to verify product safety, efficacy and user experience.

IV. Regulatory Classification Shaping Design Routes

The regulatory classification of microneedle products - cosmetics, Class I/II/III medical devices, or combination products with pharmaceuticals - fundamentally determines design complexity and development cycle.

• Cosmetic-grade products: Limited to basic skin cleansing and moisturizing. Claims about microneedle-enhanced permeation or therapeutic effects are prohibited, leading to relatively simple design.
• Medical device-grade products: Any product designed to penetrate the skin barrier is regulated as a medical device. Radiofrequency microneedles for aesthetics and injection-type microneedles are generally categorized as Class III medical devices, requiring rigorous clinical trials and registration approval. Therefore, manufacturers must incorporate comprehensive risk management at the initial design stage and establish a quality management system compliant with ISO 13485.

Conclusion

Microneedle product design is a highly scenario-oriented discipline. Manufacturers need to act not only as processors, but also as interpreters of clinical demands and integrators of interdisciplinary solutions. Behind every successful product, from vaccine patches and smart insulin pumps to household beauty devices and high-end aesthetic equipment, lies profound understanding of specific clinical scenarios, precise mastery of materials and manufacturing techniques, and clear planning for regulatory compliance.

With the advancement of precision medicine and personalized therapy, manufacturers capable of providing customized on-demand microneedle solutions will gain a competitive edge in the marketplace.